A groundbreaking new treatment that could potentially reverse or halt the progression of traumatic brain injury (TBI) is set to be developed at La Trobe University’s newly launched Bio Innovation Hub.
The $8 million state-of-the-art biotechnology facility was officially opened today by Victorian Government Minister Colin Brooks and La Trobe Vice-Chancellor Professor Theo Farrell.
The Bio Innovation Hub, funded by the Victorian Higher Education State Investment Fund (VHESIF), aims to support world-leading biotechnology and agri-technology businesses. The purpose-built facility boasts PC2 “wet” laboratories and world-class equipment, making it one of the few facilities of its kind in the state, designed to help businesses commercialize their research discoveries.
Minister Brooks emphasised the hub’s role in preparing students for Victoria’s booming $40 billion biotech sector. “This new hub at La Trobe University will empower students to gain invaluable industry knowledge and experience,” said Brooks.
Professor Farrell highlighted the hub’s importance to La Trobe’s research and innovation precinct, which is part of the University City of the Future initiative. “The Bio Innovation Hub will connect La Trobe’s world-class research capabilities with pioneering industries, creating a catalyst for growth and innovation,” he stated.
The facility will also provide students with real-world research experience, enhancing their future career opportunities.
The hub will house start-ups and small to medium-sized enterprises in biotechnology and agri-technology, offering bespoke facilities within La Trobe’s Research and Innovation Precinct. The first occupants include La Trobe spin-out AlleSense, Aeterna Health, and VivaZome Therapeutics Pty Ltd.
VivaZome CEO and Managing Director Xenia Sango expressed pride in being among the first occupants. The hub offers significant benefits, including access to state-of-the-art equipment, a world-class university research network, potential partnerships with leading researchers and industry, and access to top talent.
VivaZome focuses on developing and commercialising customised Extracellular Vesicles (EVs), which have the potential to transport key medical supplies to targeted parts of the body. Their targeted treatments for neurodegenerative diseases, including TBI and stroke, hold great promise.
“By delivering these therapeutic EVs directly to the injured brain, we aim to repair damaged cells and potentially restore lost functions, offering improved quality of life for patients with TBI,” said Sango. She noted that VivaZome’s EVs could reduce inflammation, preventing further injury and offering a versatile and powerful treatment platform.
With clinical trials anticipated within three years, the Bio Innovation Hub at La Trobe University is poised to make significant strides in biotechnology and agri-technology, fostering innovation and collaboration in Victoria’s thriving biotech sector.
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
